BR100 Increased By (1.02%)
BR30 Increased By (1.71%)
KSE100 Increased By (0.58%)
KSE30 Increased By (0.65%)
BECO 6.03 Increased By ▲ 0.26 (4.51%)
BML 52.61 Decreased By ▼ -0.39 (-0.74%)
BOP 34.23 Increased By ▲ 0.24 (0.71%)
CNERGY 8.16 Increased By ▲ 0.05 (0.62%)
DCL 12.23 Increased By ▲ 0.03 (0.25%)
FCCL 53.80 Increased By ▲ 0.97 (1.84%)
FCSC 5.24 Increased By ▲ 0.17 (3.35%)
FFL 18.03 Increased By ▲ 0.08 (0.45%)
FNEL 1.30 Increased By ▲ 0.01 (0.78%)
HUMNL 11.00 Increased By ▲ 0.12 (1.1%)
KEL 8.07 Increased By ▲ 0.05 (0.62%)
KOSM 5.39 Decreased By ▼ -0.13 (-2.36%)
MLCF 87.90 Increased By ▲ 1.39 (1.61%)
NBP 186.60 Increased By ▲ 1.44 (0.78%)
PACE 10.75 Increased By ▲ 0.17 (1.61%)
PAEL 39.95 Increased By ▲ 0.53 (1.34%)
PIAHCLA 26.19 Decreased By ▼ -0.03 (-0.11%)
PIBTL 17.32 Increased By ▲ 0.65 (3.9%)
PPL 233.49 Increased By ▲ 5.31 (2.33%)
PRL 34.98 Increased By ▲ 0.30 (0.87%)
PTC 67.71 Increased By ▲ 2.38 (3.64%)
SEARL 90.90 Increased By ▲ 0.77 (0.85%)
SSGC 27.20 Increased By ▲ 0.60 (2.26%)
TELE 8.57 Increased By ▲ 0.29 (3.5%)
THCCL 60.85 Increased By ▲ 2.35 (4.02%)
TPLP 8.78 Increased By ▲ 0.56 (6.81%)
TREET 24.65 Increased By ▲ 0.12 (0.49%)
TRG 71.50 Increased By ▲ 1.79 (2.57%)
WAVES 10.01 Increased By ▲ 0.07 (0.7%)
WTL 1.27 Decreased By ▼ -0.01 (-0.78%)
By

KARACHI: The Drug Regulatory Authority of Pakistan (DRAP) has registered’ another locally produced ventilator, ‘Innovent’, in Pakistan, sources said Tuesday.

As per details, the Innovent ventilator, manufactured by Essence Industries Karachi, has successfully completed its clinical trials.

DRAP has officially registered the Innovent ventilator and issued a license to Essence Industries for its local production. In addition to meeting domestic demand, the ventilators will also be exported, contributing to the Pakistan’s economy.

The Innovent ventilator has a shelf life of five years and is specifically designed for use by elderly patients, DRAP sources added.

Talking to a private television channel, DRAP CEO Dr. Asim Rauf said the priority of promoting Made in Pakistan medicines and medical equipment.

“Pakistan’s pharmaceutical industry has entered a new era, and the export of locally produced ventilators will generate significant foreign exchange for the country. These live-saving machines will also serve as a symbol of Pakistan’s global recognition,” Dr. Asim Rauf stated. He further highlighted that the success of Made in Pakistan medical devices reflects the country’s growing technological capabilities and commitment to innovation.

Earlier in 2021, the Drug Regulatory Authority of Pakistan (DRAP) registered an indigenously-developed intensive care unit (ICU) ventilator named “i-LIVE”.

The life-support machine was developed by the Pakistan Atomic Energy Commission (PAEC).

Chief Executive Officer of the DRAP Dr. Asim Rauf said that the i-LIVE ventilator was registered for a five-year period under the DRAP Act 2012 after its thorough technical examination.

Comments

Comments are closed for this article.